AMERICAN SOCIETY OF DERMATOPATHOLOGYPub 78
Pub 78
Balance Sheet
Fiscal Year Start:
Jul 1
Assets in 2024 (Year End)
$3,398,832
Investments
79%
Cash & Equivalents
12%
Prepaid Expenses
3%
Other Assets
3%
Property, Plant, & Equipment (net)
3%
Receivables (Non-Related)
0%
Related-Party Receivables
0%
Inventories
0%
Liabilities in 2024 (Year End)
$434,692
Deferred Revenue
87%
Payables & Accruals
10%
Other Liabilities
3%
Grants Payable
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$508,603
$409,170
-20%
Receivables (Non-Related)
-
-
-
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$69,987
$112,428
+61%
Investments
$2,387,948
$2,677,378
+12%
Property, Plant, & Equipment (net)
$115,671
$89,816
-22%
Other Assets
$119,521
$110,040
-8%
Total Assets
$3,201,730
$3,398,832
+6%
Liabilities
2023
2024
Change
Payables & Accruals
$42,064
$45,132
+7%
Grants Payable
-
-
-
Deferred Revenue
$373,956
$378,520
+1%
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
$18,467
$11,040
-40%
Total Liabilities
$434,487
$434,692
+0%
Net assets
2023
2024
Change
Restricted Net Assets
-
-
-
Unrestricted Net Assets
$2,767,243
$2,964,140
+7%
Net assets
2023
2024
Change
Net assets
+$2,767,243
+$2,964,140
+7%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)